Mechanisms of action of the small conductance Ca2+-activated K+-channel modulator AP30663, a novel compound being developed for treatment of atrial fibrillation in man

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Preclinical pharmacotherapy Antiarrhythmic Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo

Copenhagen N (Denmark)

8 More presentations in this session

Presentation thumbnail
Associate Professor N. Edvardsson (Gothenburg, SE)
Presentation thumbnail
Doctor J. Diness (Frederiksberg, DK)
Presentation thumbnail
Miss H. Chaudhry (London, GB)
Presentation thumbnail
Associate Professor H. Pan (Saint Louis, US)
Presentation thumbnail
Professor M. Grunnet (Copenhagen N, DK)

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET

ESC 365 is supported by

ESC 365 is supported by